Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

ClinicalTrials.gov ID: NCT02217475

Public ClinicalTrials.gov record NCT02217475. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis

Study identification

NCT ID
NCT02217475
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Tobira Therapeutics, Inc.
Industry
Enrollment
289 participants

Conditions and interventions

Interventions

  • Cenicriviroc Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 17, 2014
Primary completion
Jun 29, 2016
Completion
Jun 21, 2017
Last update posted
May 9, 2019

2014 – 2017

United States locations

U.S. sites
40
U.S. states
21
U.S. cities
36
Facility City State ZIP Site status
Not listed Dothan Alabama 36305
Not listed Phoenix Arizona 85054
Not listed Tucson Arizona 85712
Not listed Rialto California 92377
Not listed San Diego California 92120
Not listed San Diego California 92161
Not listed San Francisco California 94115
Not listed Littleton Colorado 80120
Not listed Miami Florida 33136
Not listed Tampa Florida 33606
Not listed Chicago Illinois 60612
Not listed Louisville Kentucky 40202
Not listed New Orleans Louisiana 70112
Not listed Baltimore Maryland 21202
Not listed Baltimore Maryland 21287
Not listed Chevy Chase Maryland 20815
Not listed Lutherville Maryland 21093
Not listed Boston Massachusetts 02114
Not listed Worcester Massachusetts 01655
Not listed Ann Arbor Michigan 48109
Not listed Saint Paul Minnesota 55114
Not listed Flowood Mississippi 39232
Not listed Jackson Mississippi
Not listed Tupelo Mississippi 38801
Not listed Buffalo New York 14201
Not listed New York New York 10029
Not listed Durham North Carolina 27710
Not listed Raleigh North Carolina 27612
Not listed Winston-Salem North Carolina 27103
Not listed Cincinnati Ohio 45249
Not listed Chattanooga Tennessee 37421
Not listed Germantown Tennessee 38138
Not listed Houston Texas 77030
Not listed Houston Texas 78234
Not listed Live Oak Texas 78233
Not listed San Antonio Texas 78215
Not listed San Antonio Texas 78233
Not listed Salt Lake City Utah 84132
Not listed Richmond Virginia 23298
Not listed Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02217475, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 9, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02217475 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →